financetom
Business
financetom
/
Business
/
Update: Emera Q4 Adjusted Earnings Beat Estimates
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Update: Emera Q4 Adjusted Earnings Beat Estimates
Feb 21, 2025 8:45 AM

11:18 AM EST, 02/21/2025 (MT Newswires) -- (Adds comment and updates shares.)

Emera ( EMRAF ) on Friday reported fourth-quarter adjusted earnings that beat estimates.

The utility-holding company posted adjusted earnings, excluding most one-time items, of $246 million, or $0.84 per share, beating the FactSet analyst consensus forecast of $0.76 per share and above the $175 million, or $0.63, recorded in the year-prior quarter.

Revenue was not disclosed.

Emera ( EMRAF ) attributed the higher adjusted earnings to increased income across all of its regulated utilities, as well as higher corporate income tax recovery.

These were partially offset by lower equity earnings due to the sale of the Labrador Island Link in the second quarter of 2024, higher corporate operating, maintenance and general expense due to the timing of long-term incentive expenses and related hedges, increased Corporate interest expense, and decreased earnings at Emera Energy.

Net income was $154 million, or $0.52 per share, below the FactSet analyst consensus estimate of $0.77 and lower than the year-ago pr of $289 million, or $1.04 per share.

"2024 was a year of significant progress for Emera ( EMRAF )," chief executive Scott Balfour said. "We delivered on our key objectives and in doing so, have strategically positioned the business to meet the evolving demands within our industry and capitalize on the robust organic growth opportunities in our Florida utilities."

For 2025, Emera ( EMRAF ) said it will focus on executing its five-year $20 billion capital plan, grid modernization and infrastructure expansion, as well as growing earnings and cash flow.

National Bank of Canada maintained its sector-perform rating and $56.00 price target on Emera ( EMRAF ) shares following the results.

"With a solid finish to 2024, and the company's five-year capital plan in check, we expect modest changes to our long-term estimates and valuation following the company's conference call," National Bank said.

Emera ( EMRAF ) shares were last seen up $0.28 to $56.89 on the Toronto Stock Exchange.

Price: 56.89, Change: +0.28, Percent Change: +0.49

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Alnylam Pharmaceuticals Swings to Q4 Earnings, Revenue Rises
Alnylam Pharmaceuticals Swings to Q4 Earnings, Revenue Rises
Feb 13, 2025
08:23 AM EST, 02/13/2025 (MT Newswires) -- Alnylam Pharmaceuticals ( ALNY ) reported Q4 non-GAAP net income Thursday of $0.06 per diluted share, swinging from a net loss of $0.77 per share a year earlier. Analysts polled by FactSet expected a loss of $0.26 per share. Revenue for the quarter ended Dec. 31 was $593.2 million, up from $439.7 million...
Steven Madden to buy UK-based luxury shoe brand Kurt Geiger in $360 million deal
Steven Madden to buy UK-based luxury shoe brand Kurt Geiger in $360 million deal
Feb 13, 2025
(Reuters) - Shoe designer Steven Madden said on Thursday it would buy UK-based luxury brand Kurt Geiger in an all-cash deal valued at 289 million pounds ($360.09 million), expanding its presence in international markets. The New York-based owner of brands such as Dolce Vita and Betsey Johnson will buy the company from private equity firm Cinven. Kurt Geiger's brand portfolio...
Blueprint Medicines Q4 Loss Narrows, Revenue Rises
Blueprint Medicines Q4 Loss Narrows, Revenue Rises
Feb 13, 2025
08:24 AM EST, 02/13/2025 (MT Newswires) -- Blueprint Medicines ( BPMC ) reported a Q4 net loss Thursday of $0.79 per diluted share, narrowing from a loss of $1.82 a year earlier. Analysts polled by FactSet expected a loss of $0.67. Revenue for the quarter ended Dec. 31, 2024, was $146.4 million, up from $72 million a year earlier. Analysts...
Crocs Smashes Q4 Earnings Expectations Amid Accelerated China Growth; Stock Jumps
Crocs Smashes Q4 Earnings Expectations Amid Accelerated China Growth; Stock Jumps
Feb 13, 2025
Crocs, Inc. ( CROX ) shares are trading higher after the company reported fourth-quarter results. Crocs ( CROX ) registered quarterly adjusted earnings per share of $2.52, beating the street view of $2.26 as the Crocs brand exceeded expectations in North America, with strong growth in China accelerating. Quarterly sales of $989.773 million (up 3.1% year over year) outpaced the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved